Celsion Corp. (CLSN:NASDAQ) Annual Reports & Investor Relations Material

Overview

Celsion Corporation is a cutting-edge oncology drug development company that utilizes proprietary heat-activated liposomal technology to create targeted chemotherapeutic oncology drugs. The company is dedicated to advancing cancer treatment options and improving patient outcomes.

Annual Reports

Frequently Asked Questions

What is Celsion Corp.'s ticker?

Celsion Corp.'s ticker is CLSN

What exchange is Celsion Corp. traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Celsion Corp.'s headquarters?

They are based in Lawrenceville, New Jersey

How many employees does Celsion Corp. have?

There are 11-50 employees working at Celsion Corp.

What is Celsion Corp.'s website?

It is http://www.celsion.com

What type of sector is Celsion Corp.?

Celsion Corp. is in the Healthcare sector

What type of industry is Celsion Corp.?

Celsion Corp. is in the Biotechnology industry

Who are Celsion Corp.'s peers and competitors?

The following five companies are Celsion Corp.'s industry peers:

- Epizyme Inc

- La Jolla Pharmaceutical Company

- Proteomics International

- FibroGen

- Emergent BioSolutions